Innovative Healthcare

Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference

Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to...

Catalio Capital Management Raises More than $325M in its Oversubscribed Second Credit Fund to Enable Healthcare Innovation Through Structured Credit

NEW YORK--(BUSINESS WIRE)--Jan 7, 2026-- Catalio Capital Management, LP (“Catalio”), a leading innovative healthcare investment firm, today announced the successful...